Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FAIR: Microbiota Therapy for Antibiotic-Resistant Bacterial Colonization
NCT05835206Phase 2Recruiting
- Sponsor
- Emory University
- Start
- Apr 2024
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in organism colonization (2 arms), sponsored by Emory University. Primary endpoints: Change in stool MDRO colony-forming unit (CFU) density at Week 28 and Change in proportion of MDRO colonized participants after last treatment cycle at Week 28. Started Apr 2024; status: recruiting.
02
Conditions
organism colonization
Beyond the preview
Go deeper on NCT05835206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05835206.